COMMUNITY CLINICAL ONCOLOGY PROGRAM

West Metro-Minneapolis社区临床肿瘤学项目（WMMCCOP） 代表一个由七间医院组成的联盟， NCI资助的CHOP计划，已经制定了一个共同的方法， 管理癌症病人，并有既定的机制， 协议和患者管理指南的整合。 该财团 拥有一个社区范围的计算机化数据管理系统（TUMORS）， 前瞻性数据收集。 七家医院一起看到了一个 平均每年有3,600名新的癌症患者。 20核心 研究人员还在癌症项目上进行了广泛的合作 发展 几名研究者有ECOG癌症控制经验 通过明尼苏达大学（UM）的附属机构。 WMMCCOP打算 目的：与UM-ECOG在设计、使用 和方案的质量控制;建立数据管理计划， 高度的质量控制，对医生的反馈和 为NCI的总体评估和扩散假设提供数据; 设立机制，管制药剂的使用， 现有的、有经验的药房。 1981年，WMMCCOP的调查人员 在NCI批准的方案中纳入了115名患者。 47名患者 1982年4月至6月进入研究方案。 第一年 WMMCCOP手术，研究者计划将245例患者录入ECOG 协议.

The West Metro-Minneapolis Community Clinical Oncology Program (WMMCCOP) represents a consortium of seven hospitals which, through its operational NCI-funded CHOP program, has already developed a common approach to the management of cancer patients and has an established mechanism for the integration of protocols and patient management guidelines. The consortium has a community-wide, computerized data management system (TUMORS) capable of prospective data collection. Together, the seven hospitals see an average of 3,600 new, analytic cancer patients per year. The twenty core investigators have also worked extensively together on cancer program development. Several investigators have experience as ECOG cancer control affiliates through the University of Minnesota (UM). The WMMCCOP intends to: develop a close working relationship with UM-ECOG on the design, use and quality control of protocols; establish a data management plan with a high degree of quality control, feedback to physicians and capability of providing data for NCI's overall evaluation and diffusion hypothesis; and establish a mechanism to control the use of pharmaceutical agents through its existing, experienced pharmacy. During 1981, WMMCCOP investigators entered 115 patients on NCI approved protocols. Forty-seven patients were entered on protocol from April to June, 1982. During the first year of WMMCCOP operation, investigators intend to enter 245 patients onto ECOG protocols.